S100A9 and rheumatoid arthritis: Therefore, neutrophil-derived proteins, or NET components (i.e., S100A9/S100A8, elastase, and cell free-DNA) in the plasma and SF of RA patients were suggested as prospective disease activity biomarkers for RA (17, 41–43).